Streetbeat News

Stock Prices

ALB

Albemarle's stock price increased following an upgrade from Berenberg, moving from Hold to Buy, with a new price target set at $160, up from $130.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:44 am

NKE

Nike's stock price increased following an upgrade from B of A Securities, changing its rating from Neutral to Buy and raising the price target from $110 to $113.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:42 am

MNPR

JonesTrading analyst Soumit Roy upgrades Monopar Therapeutics (MNPR) from Hold to Buy with a $2 price target.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:39 am

STZ

Constellation Brands projects its adjusted earnings per share (EPS) for fiscal year 2025 to be between $13.50 and $13.80, surpassing the estimated $13.44.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:37 am

VERA

Vera Therapeutics' stock price increased following news that Alpine Immune is being acquired by Vertex, indicating market optimism around biotech acquisitions.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:35 am

UNH

Bloomberg reported that UnitedHealth's Chair and executives sold $102M in stock before the news of a US probe into the company became public. This significant stock sale occurred ahead of potentially damaging public information, raising questions about insider trading and its impact on UnitedHealth's stock price.

Portfolio Pulse from Charles Gross

April 11, 2024 | 11:35 am

STZ

Constellation Brands projects a net sales growth of 6% to 7% by FY25, indicating a positive outlook for the company's future revenue.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:35 am

FANG

Mizuho analyst Nitin Kumar has maintained a Buy rating on Diamondback Energy (NASDAQ:FANG) and increased the price target from $200 to $217.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:34 am

GPRK

GeoPark has submitted a binding offer to acquire a non-operated working interest in unconventional blocks in the Neuquen Basin, Argentina. This move aligns with its strategy for expansion in Latin America's prime oil and gas basins. The acquisition is expected to add over 5,000 net boepd of production immediately upon closing.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:33 am

ELYM

Eliem Therapeutics has announced a definitive agreement to acquire Tenet and has also entered into a securities purchase agreement for a $120 million private placement, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:33 am